Previous evidence described the genetic screening of hereditary syndromes accompanied by the genetic mutations in genes (Table 3) such as FOXC2, FLT-4, and SOX18 for lymphedema-distichiasis, Milroy disease, and hypotrichosis-lymphedema-telangiectasia, respectively. This evidence concerns the gene FOXC2 and Milroy disease.